New York State Common Retirement Fund Madrigal Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 46,445 shares of MDGL stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,445
Previous 51,173
9.24%
Holding current value
$10.1 Million
Previous $14.3 Million
31.25%
% of portfolio
0.01%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
21.9MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$541 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$448 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$430 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$417 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$403 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.72B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...